Point of Care Diagnostics Market, By Product (Glucose Testing, Hb1Ac Testing, Coagulation, Fertility, Infectious Diseases, and Cardiac Markers), By Platform, By End-Use, By Country, and By Region Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
|
Report ID
AV4055
|
Published Date
June 2025
|
Pages
400
|
Industry
Healthcare
|
|
|
Base Year
2025
|
Historical Data
2019-2024
|
Delivery Timeline
24 Hour
|
REPORT HIGHLIGHT
Point of Care Diagnostics Market size was valued at US$ 46,987.34 Million in 2024, expanding at a CAGR of 6.0% from 2025 to 2032.
Point-of-care testing (POCT), also known as near-patient or bedside testing, refers to medical diagnostic testing performed at or near the site of patient care—at the time and place of the clinical encounter. This approach contrasts with traditional laboratory-based testing, where samples are collected and sent to a centralized lab for analysis, often resulting in delayed turnaround times. POCT is designed to deliver rapid, actionable results, allowing for immediate clinical decisions and improved patient outcomes. It can be deployed across a wide range of settings, including hospitals, clinics, physician offices, emergency departments, retail health centers, and even patients’ homes. The hallmark of POCT is its speed and convenience, typically enabled by portable, user-friendly devices that require minimal training to operate. POCT encompasses a broad spectrum of diagnostic tests, ranging from simple blood glucose monitoring to advanced molecular assays for detecting infectious diseases—making it a critical component in modern, responsive healthcare delivery.
Point of Care Diagnostics Market- Market Dynamics
The point-of-care diagnostics (POCT) market is being driven by the growing global burden of infectious and chronic diseases, which underscores the need for fast, affordable, and accessible diagnostic solutions. According to the World Health Organization (WHO), approximately 39.9 million people were living with HIV worldwide in 2023, with 1.3 million new infections reported during the year—highlighting the critical demand for rapid, on-site testing capabilities.
Technological advancements such as device miniaturization, integration of biosensors, and the application of artificial intelligence are enhancing the accuracy, usability, and efficiency of POCT devices. Moreover, the increasing shift toward decentralized healthcare models and the rising popularity of self-testing solutions, particularly in emerging markets, are opening new avenues for growth. Efforts in research and development aimed at creating low-cost, high-throughput POCT technologies for underserved populations also present significant expansion opportunities. Despite these growth drivers, the market faces challenges. Intense pricing pressure due to competitive dynamics, along with the complexity and length of regulatory approval processes, can hinder product commercialization and market penetration. Addressing these barriers will be key to unlocking the full potential of POCT in transforming global healthcare delivery.
Point of Care Diagnostics Market- Segmentation Analysis:
The Global Point of Care Diagnostics Market is segmented on the basis of Product, Platform, End-Use, and Region.
By product, the market is divided into glucose testing, hb1ac testing, coagulation, fertility, infectious diseases, cardiac markers, thyroid stimulating hormone, hematology, primary care systems, decentralized clinical chemistry, feces, lipid testing, cancer marker, blood gas/electrolytes, ambulatory chemistry, drug abuse testing, and urinalysis. Infectious diseases accounted for the largest share of the market. This is largely attributable to the persistently high worldwide burden of contagious diseases, such as respiratory infections, sexually transmitted infections, and emerging viral threats. The rapid and precise diagnosis of these entities is key to successful treatment, control, and public health management and renders POCT solutions for infectious diseases of critical importance. The capability to rapidly detect pathogens at the point of care allows for timely intervention, decreases disease transmission, and minimizes the burden on centralized laboratory facilities, especially in outbreak situations. Cardiac markers are the fastest-growing segment in the market. This is due mainly to the increasing global burden of cardiovascular diseases, which are a major cause of morbidity and mortality. Fast and precise diagnosis of cardiac events, including myocardial infarction, at the point of care, is essential for early intervention and patient outcome improvement. The growing emphasis on early detection, along with advances in sensitive and specific cardiac biomarker assays for POCT devices, further accelerates the growth of this segment.
By end-use, the market is segmented into clinics, hospitals, home, assisted living healthcare facilities. The hospitals acquired a majority share in the market. Hospitals are in a central position as the first points of contact for acute patient care, emergency care, and a broad range of diagnostic services. Hospital POCT devices provide immediate triage, allow instant clinical decisions, and enhance patient flow, especially in critical care environments such as emergency departments & intensive care units. Providing rapid results for sepsis, cardiac events, and infectious diseases at the bedside of patients greatly improves the effectiveness of treatment and shortens hospital stays. The home care setting is the fastest-growing segment in the market. This is largely due to the rise in patient inclination toward convenient, personalized, and accessible healthcare solutions. The prevalence of chronic diseases such as diabetes and cardiovascular diseases requires frequent screening, and POCT devices used at home give patients the ability to control their health actively away from traditional clinical settings. Technical improvements have created easy-to-use, transportable, and networked devices for self-testing and distant monitoring, with results frequently sent automatically to healthcare professionals.
Point of Care Diagnostics Market- Geographical Insights
North America holds the largest share of the point-of-care diagnostics market, driven by its highly developed and technologically advanced healthcare infrastructure, substantial healthcare expenditure, and rapid adoption of innovative diagnostic technologies. The region also faces a high prevalence of chronic diseases and benefits from a robust regulatory framework that supports the development and commercialization of POCT solutions. Additionally, the presence of major industry players, strong investments in research and development, and favorable reimbursement policies further reinforce North America’s leadership in the market.
Conversely, the Asia-Pacific region is projected to witness the fastest growth in the POCT market. This rapid expansion is largely attributed to the ongoing development of healthcare infrastructure, particularly in emerging economies like China and India, coupled with a growing and underserved patient population. The increasing incidence of both infectious and chronic diseases in these countries is driving strong demand for accessible, cost-effective diagnostic tools. Furthermore, rising disposable incomes, greater health awareness, and supportive government initiatives aimed at improving healthcare access in rural and remote areas are fueling sustained market growth across the region.
Point of Care Diagnostics Market- Competitive Landscape:
The global point-of-care diagnostics (POCT) market is highly competitive, characterized by the presence of well-established multinational corporations alongside agile, specialized diagnostic firms. Major players such as F. Hoffmann-La Roche Ltd., Abbott, Siemens Healthcare GmbH, and Danaher Corporation maintain a strong market position through robust research and development capabilities, expansive product portfolios, and widespread distribution networks. These companies frequently pursue strategic partnerships, mergers, and acquisitions to broaden their market reach and enhance their technological offerings. The competitive landscape is continually fueled by rapid technological advancements and increasing demand for accurate, user-friendly, and cost-effective diagnostic solutions. To meet evolving needs in decentralized care, companies are focusing on integrated platforms that deliver faster results and support improved patient management.
Recent Developments:
- March 2025: Accelerate Diagnostics submitted its Accelerate WAVE™ System and Positive Blood Culture Gram-Negative Test Kit to the U.S. FDA for 510(k) clearance, aiming to advance rapid in vitro microbiology diagnostics.
- March 2025: Advanced Instruments, a subsidiary of Patricia Industries, entered into a definitive agreement to acquire Nova Biomedical for USD 2.2 billion. This move will establish a diversified, global life sciences tools platform under the Nova Biomedical brand.
- May 2024: F. Hoffmann-La Roche Ltd. received FDA approval for its HPV Self-Testing Kit, designed to detect early cervical cancer risk and enhance screening accessibility at the point of care.
- April 2024: Abbott secured U.S. FDA clearance for its i-STAT TBI Cartridge, enabling rapid, bedside evaluation of traumatic brain injury (TBI) using whole blood, delivering lab-quality results in just 15 minutes to support urgent clinical decisions.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL POINT OF CARE DIAGNOSTICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- F. Hoffmann-La Roche Ltd.
- Qiagen
- Danaher Corporation
- Becton Dickinson (BD)
- bioMérieux
- Abbott
- Siemens Healthcare GmbH
- Werfen
- Nova Biomedical
- Trividia Health, Inc.
GLOBAL POINT OF CARE DIAGNOSTICS MARKET, BY PRODUCT - MARKET ANALYSIS, 2019 - 2032
- Glucose Testing
- Hb1Ac Testing
- Coagulation
- Fertility
- Infectious Diseases
- Cardiac Markers
- Thyroid Stimulating Hormone
- Hematology
- Primary Care Systems
- Decentralized Clinical Chemistry
- Feces
- Lipid Testing
- Cancer Marker
- Blood Gas/Electrolytes
- Ambulatory Chemistry
- Drug Abuse Testing
- Urinalysis
GLOBAL POINT OF CARE DIAGNOSTICS MARKET, BY PLATFORM- MARKET ANALYSIS, 2019 - 2032
- Lateral Flow Assays
- Dipsticks
- Microfluidics
- Molecular Diagnostics
- Immunoassays
GLOBAL POINT OF CARE DIAGNOSTICS MARKET, BY END USE- MARKET ANALYSIS, 2019 - 2032
- Clinics
- Hospitals
- Home
- Assisted Living Healthcare Facilities
- Laboratory
GLOBAL POINT OF CARE DIAGNOSTICS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Point of Care Diagnostics Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Point of Care Diagnostics Market Snippet By Product
2.1.2. Point of Care Diagnostics Market Snippet By Platform
2.1.3. Point of Care Diagnostics Market Snippet By End Use
2.1.4. Point of Care Diagnostics Market Snippet by Country
2.1.5. Point of Care Diagnostics Market Snippet by Region
2.2. Competitive Insights
3. Point of Care Diagnostics Key Market Trends
3.1. Point of Care Diagnostics Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Point of Care Diagnostics Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Point of Care Diagnostics Market Opportunities
3.4. Point of Care Diagnostics Market Future Trends
4. Point of Care Diagnostics Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Point of Care Diagnostics Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Point of Care Diagnostics Market Landscape
6.1. Point of Care Diagnostics Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Point of Care Diagnostics Market – By Product
7.1. Overview
7.1.1. Segment Share Analysis, By Product, 2024 & 2032 (%)
7.1.2. Glucose Testing
7.1.3. Hb1Ac Testing
7.1.4. Coagulation
7.1.5. Fertility
7.1.6. Infectious Diseases
7.1.7. Cardiac Markers
7.1.8. Thyroid Stimulating Hormone
7.1.9. Hematology
7.1.10. Primary Care Systems
7.1.11. Decentralized Clinical Chemistry
7.1.12. Feces
7.1.13. Lipid Testing
7.1.14. Cancer Marker
7.1.15. Blood Gas/Electrolytes
7.1.16. Ambulatory Chemistry
7.1.17. Drug Abuse Testing
7.1.18. Urinalysis
8. Point of Care Diagnostics Market – By Platform
8.1. Overview
8.1.1. Segment Share Analysis, By Platform, 2024 & 2032 (%)
8.1.2. Lateral Flow Assays
8.1.3. Dipsticks
8.1.4. Microfluidics
8.1.5. Molecular Diagnostics
8.1.6. Immunoassays
9. Point of Care Diagnostics Market – By End Use
9.1. Overview
9.1.1. Segment Share Analysis, By End Use, 2024 & 2032 (%)
9.1.2. Clinics
9.1.3. Hospitals
9.1.4. Home
9.1.5. Assisted Living Healthcare Facilities
9.1.6. Laboratory
10. Point of Care Diagnostics Market– By Geography
10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
10.2. North America
10.2.1. Overview
10.2.2. Point of Care Diagnostics Key Manufacturers in North America
10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.2.4. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.2.5. North America Market Size and Forecast, By Platform, 2019 - 2032 (US$ Million)
10.2.6. North America Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.2.7. U.S.
10.2.7.1. Overview
10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.2.7.3. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.2.7.4. U.S. Market Size and Forecast, By Platform, 2019 - 2032 (US$ Million)
10.2.7.5. U.S. Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.2.8. Canada
10.2.8.1. Overview
10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.2.8.3. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.2.8.4. Canada Market Size and Forecast, By Platform, 2019 - 2032 (US$ Million)
10.2.8.5. Canada Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.3. Europe
10.3.1. Overview
10.3.2. Point of Care Diagnostics Key Manufacturers in Europe
10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.3.4. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.3.5. Europe Market Size and Forecast, By Platform, 2019 - 2032 (US$ Million)
10.3.6. Europe Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.3.7. Germany
10.3.7.1. Overview
10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.7.3. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.3.7.4. Germany Market Size and Forecast, By Platform, 2019 - 2032 (US$ Million)
10.3.7.5. Germany Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.3.8. UK
10.3.8.1. Overview
10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.8.3. UK Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.3.8.4. UK Market Size and Forecast, By Platform, 2019 - 2032 (US$ Million)
10.3.8.5. UK Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.3.9. France
10.3.9.1. Overview
10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.9.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.3.9.4. France Market Size and Forecast, By Platform, 2019 - 2032 (US$ Million)
10.3.9.5. France Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.3.10. Italy
10.3.10.1. Overview
10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.10.3. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.3.10.4. Italy Market Size and Forecast, By Platform, 2019 - 2032 (US$ Million)
10.3.10.5. Italy Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.3.11. Spain
10.3.11.1. Overview
10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.11.3. Spain Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.3.11.4. Spain Market Size and Forecast, By Platform, 2019 - 2032 (US$ Million)
10.3.11.5. Spain Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.3.12. The Netherlands
10.3.12.1. Overview
10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.12.3. The Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.3.12.4. The Netherlands Market Size and Forecast, By Platform, 2019 - 2032 (US$ Million)
10.3.12.5. The Netherlands Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.3.13. Sweden
10.3.13.1. Overview
10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.13.3. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.3.13.4. Sweden Market Size and Forecast, By Platform, 2019 - 2032 (US$ Million)
10.3.13.5. Sweden Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.3.14. Russia
10.3.14.1. Overview
10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.14.3. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.3.14.4. Russia Market Size and Forecast, By Platform, 2019 - 2032 (US$ Million)
10.3.14.5. Russia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.3.15. Poland
10.3.15.1. Overview
10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.15.3. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.3.15.4. Poland Market Size and Forecast, By Platform, 2019 - 2032 (US$ Million)
10.3.15.5. Poland Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.3.16. Rest of Europe
10.3.16.1. Overview
10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.16.3. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.3.16.4. Rest of the Europe Market Size and Forecast, By Platform, 2019 - 2032 (US$ Million)
10.3.16.5. Rest of the Europe Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.4. Asia Pacific (APAC)
10.4.1. Overview
10.4.2. Point of Care Diagnostics Key Manufacturers in Asia Pacific
10.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.4.4. APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.4.5. APAC Market Size and Forecast, By Platform, 2019 - 2032 (US$ Million)
10.4.6. APAC Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.4.7. China
10.4.7.1. Overview
10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.7.3. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.4.7.4. China Market Size and Forecast, By Platform, 2019 - 2032 (US$ Million)
10.4.7.5. China Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.4.8. India
10.4.8.1. Overview
10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.8.3. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.4.8.4. India Market Size and Forecast, By Platform, 2019 - 2032 (US$ Million)
10.4.8.5. India Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.4.9. Japan
10.4.9.1. Overview
10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.9.3. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.4.9.4. Japan Market Size and Forecast, By Platform, 2019 - 2032 (US$ Million)
10.4.9.5. Japan Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.4.10. South Korea
10.4.10.1. Overview
10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.10.3. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.4.10.4. South Korea Market Size and Forecast, By Platform, 2019 - 2032 (US$ Million)
10.4.10.5. South Korea Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.4.11. Australia
10.4.11.1. Overview
10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.11.3. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.4.11.4. Australia Market Size and Forecast, By Platform, 2019 - 2032 (US$ Million)
10.4.11.5. Australia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.4.12. Indonesia
10.4.12.1. Overview
10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.12.3. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.4.12.4. Indonesia Market Size and Forecast, By Platform, 2019 - 2032 (US$ Million)
10.4.12.5. Indonesia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.4.13. Thailand
10.4.13.1. Overview
10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.13.3. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.4.13.4. Thailand Market Size and Forecast, By Platform, 2019 - 2032 (US$ Million)
10.4.13.5. Thailand Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.4.14. Philippines
10.4.14.1. Overview
10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.14.3. Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.4.14.4. Philippines Market Size and Forecast, By Platform, 2019 - 2032 (US$ Million)
10.4.14.5. Philippines Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.4.15. Rest of APAC
10.4.15.1. Overview
10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.15.3. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.4.15.4. Rest of APAC Market Size and Forecast, By Platform, 2019 - 2032 (US$ Million)
10.4.15.5. Rest of APAC Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.5. Latin America (LATAM)
10.5.1. Overview
10.5.2. Point of Care Diagnostics Key Manufacturers in Latin America
10.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.5.4. LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.5.5. LATAM Market Size and Forecast, By Platform, 2019 - 2032 (US$ Million)
10.5.6. LATAM Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.5.7. Brazil
10.5.7.1. Overview
10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.7.3. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.5.7.4. Brazil Market Size and Forecast, By Platform, 2019 - 2032 (US$ Million)
10.5.7.5. Brazil Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.5.8. Mexico
10.5.8.1. Overview
10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.8.3. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.5.8.4. Mexico Market Size and Forecast, By Platform, 2019 - 2032 (US$ Million)
10.5.8.5. Mexico Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.5.9. Argentina
10.5.9.1. Overview
10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.9.3. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.5.9.4. Argentina Market Size and Forecast, By Platform, 2019 - 2032 (US$ Million)
10.5.9.5. Argentina Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.5.10. Colombia
10.5.10.1. Overview
10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.10.3. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.5.10.4. Colombia Market Size and Forecast, By Platform, 2019 - 2032 (US$ Million)
10.5.10.5. Colombia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.5.11. Rest of LATAM
10.5.11.1. Overview
10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.11.3. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.5.11.4. Rest of LATAM Market Size and Forecast, By Platform, 2019 - 2032 (US$ Million)
10.5.11.5. Rest of LATAM Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.6. Middle East and Africa (MEA)
10.6.1. Overview
10.6.2. Point of Care Diagnostics Key Manufacturers in Middle East and Africa
10.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.6.4. MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.6.5. MEA Market Size and Forecast, By Platform, 2019 - 2032 (US$ Million)
10.6.6. MEA Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.6.7. Saudi Arabia
10.6.7.1. Overview
10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.7.3. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.6.7.4. Saudi Arabia Market Size and Forecast, By Platform, 2019 - 2032 (US$ Million)
10.6.7.5. Saudi Arabia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.6.8. UAE
10.6.8.1. Overview
10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.8.3. UAE Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.6.8.4. UAE Market Size and Forecast, By Platform, 2019 - 2032 (US$ Million)
10.6.8.5. UAE Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.6.9. Israel
10.6.9.1. Overview
10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.9.3. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.6.9.4. Israel Market Size and Forecast, By Platform, 2019 - 2032 (US$ Million)
10.6.9.5. Israel Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.6.10. Turkey
10.6.10.1. Overview
10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.10.3. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.6.10.4. Turkey Market Size and Forecast, By Platform, 2019 - 2032 (US$ Million)
10.6.10.5. Turkey Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.6.11. Algeria
10.6.11.1. Overview
10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.11.3. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.6.11.4. Algeria Market Size and Forecast, By Platform, 2019 - 2032 (US$ Million)
10.6.11.5. Algeria Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.6.12. Egypt
10.6.12.1. Overview
10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.12.3. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.6.12.4. Egypt Market Size and Forecast, By Platform, 2019 - 2032 (US$ Million)
10.6.12.5. Egypt Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
10.6.13. Rest of MEA
10.6.13.1. Overview
10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.13.3. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
10.6.13.4. Rest of MEA Market Size and Forecast, By Platform, 2019 - 2032 (US$ Million)
10.6.13.5. Rest of MEA Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
11. Key Vendor Analysis- Point of Care Diagnostics Industry
11.1. Competitive Dashboard
11.1.1. Competitive Benchmarking
11.1.2. Competitive Positioning
11.2. Company Profiles
11.2.1. F. Hoffmann-La Roche Ltd.
11.2.2. Qiagen
11.2.3. Danaher Corporation
11.2.4. Becton Dickinson (BD)
11.2.5. bioMérieux
11.2.6. Abbott
11.2.7. Siemens Healthcare GmbH
11.2.8. Werfen
11.2.9. Nova Biomedical
11.2.10. Trividia Health, Inc.
12. 360 Degree AnalystView
13. Appendix
13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us
Related Reports
Credibility and Certifications
Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.
ISO 9001:2015
ESOMAR Corporate
GDPR Compliance
D-U-N-S Registered
BBB Accreditation
MRS
